Literature DB >> 29135310

ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia.

Müberra Namlı Kalem1, Ziya Kalem2, Tuncay Yüce3, Feride Soylemez3.   

Abstract

The aim of this study is to compare ADAMTS (A Disintegrin and Metalloprotease Domains with Thrombospondins motifs) 1, 4, 12, and 13 levels in maternal and cord blood and placental tissue between preeclampsia and uncomplicated pregnancies. The enzyme-linked immunosorbent assay (ELISA) results showed that ADAMTS 1, 4, 12, and 13 levels in the maternal and cord blood were lower in the preeclampsia group than in the control group. Based on the immunohistochemistry (IHC) results, ADAMTS 1, 4, and 12 levels in placental tissues were higher in the preeclampsia group. According to the polymerase chain reaction (PCR) results, ADAMTS 1, 4, and 12 were higher, whereas ADAMTS 13 was lower in the preeclampsia group than in the control group.

Entities:  

Keywords:  ADAMTS; Preeclampsia; cord blood; maternal blood; placenta

Mesh：

Substances：

Year:  2017        PMID： 29135310     DOI： 10.1080/10641955.2017.1397690

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN： 1064-1955            Impact factor:   2.108


  5 in total

1.  Epigenetic changes in preterm birth placenta suggest a role for ADAMTS genes in spontaneous preterm birth.

Authors:  Sneha Mani; Jayashri Ghosh; Yemin Lan; Suneeta Senapati; Teri Ord; Carmen Sapienza; Christos Coutifaris; Monica Mainigi
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

2.  The role of serum ADAMTS-1 levels in Hyperemesis Gravidarum.

Authors:  Burcu Timur; Gurhan Guney
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-20       Impact factor: 3.105

3.  Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus.

Authors:  Varun Alur; Varshita Raju; Basavaraj Vastrad; Anandkumar Tengli; Chanabasayya Vastrad; Shivakumar Kotturshetti
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

4.  Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes.

Authors:  William P Marinello; Zahra S Mohseni; Sarah J Cunningham; Christine Crute; Rong Huang; Jun J Zhang; Liping Feng
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.834

Review 5.  Molecular Advances in Preeclampsia and HELLP Syndrome.

Authors:  Angeliki Gardikioti; Theodora-Maria Venou; Eleni Gavriilaki; Evangelia Vetsiou; Ioulia Mavrikou; Konstantinos Dinas; Angelos Daniilidis; Efthymia Vlachaki
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.